THE CA-125 LEVEL AFTER NEOADJUVANT CHEMOTHERAPY FOR RELAPSE FREE SURVIVAL PREDICTION IN PATIENTS WITH ADVANCED OVARIAN CANCER CANCER

被引：0
|
作者：
Lee, Y. J. [1 ]
Kim, Y. M. [1 ]
Lee, S. H. [1 ]
Park, J. Y. [1 ]
Suh, D. S. [1 ]
Kim, D. Y. [1 ]
Kim, J. H. [1 ]
Kim, Y. T. [1 ]
Nam, J. H. [1 ]
机构：
[1] Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0720
引用
收藏
页码：1415 / 1415
页数：1
相关论文
共 50 条
  • [1] Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer
    Kang, Sokbom
    Kim, Tae-Joong
    Seo, Sang-Soo
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Park, Sang-Yoon
    GYNECOLOGIC ONCOLOGY, 2011, 120 (01) : 18 - 22
  • [2] Pretreatment CA-125 and risk of relapse in advanced ovarian cancer
    Markmann, M
    Liu, PY
    Rothenberg, ML
    Monk, BJ
    Brady, M
    Alberts, DS
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1454 - 1458
  • [3] Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer
    Ducoulombier, Simon
    Golfier, Francois
    Colomban, Olivier
    Benayoun, David
    Bolze, Pierre-Adrien
    Tod, Michel
    You, Benoit
    ANTICANCER RESEARCH, 2017, 37 (12) : 6879 - 6886
  • [4] THE USE OF CA-125 KELIM TO IDENTIFY WHICH PATIENTS CAN ACHIEVE COMPLETE CYTOREDUCTION AFTER NEOADJUVANT CHEMOTHERAPY IN ADVANCED OVARIAN CANCER
    Zouzoulas, Dimitrios
    Tzitzis, Panagiotis
    Tsolakidis, Dimitrios
    Theodoulidis, Vasilis
    Chatzistamatiou, Kimon
    Topalidou, Maria
    Grimbizis, Grigoris
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A327 - A327
  • [5] EFFECT OF NEOADJUVANT CHEMOTHERAPY ON CA-125 SECRETION AND TELOMERASE ACTIVITY IN OVARIAN CANCER
    Atallah, D.
    Antoun, S.
    Moubarak, M.
    El Kassis, N.
    Chahine, G.
    Hilal, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1411 - 1411
  • [6] CA-125 AND SURVIVAL IN OVARIAN-CANCER
    PARKER, D
    PATEL, K
    ALRED, EJ
    HARNDENMAYOR, P
    NAYLOR, B
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1988, 81 (01) : 22 - 22
  • [7] CA-125 AND SURVIVAL IN OVARIAN-CANCER
    PARKER, D
    PATEL, K
    ALRED, J
    HARNDENMAYOR, P
    NAYLOR, B
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 233 - 234
  • [8] Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
    Lee, Yong Jae
    Lee, In Ha
    Kim, Yun-Ji
    Chung, Young Shin
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    PLOS ONE, 2018, 13 (09):
  • [9] CA-125 antigen levels can predict survival in patients with advanced ovarian cancer
    Nature Clinical Practice Oncology, 2007, 4 (1): : 6 - 6
  • [10] Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
    Lee, Maria
    Chang, Min Young
    Yoo, Hanna
    Lee, Kyung Eun
    Chay, Doo Byung
    Cho, Hanbyoul
    Kim, Sunghoon
    Kim, Young Tae
    Kim, Jae-Hoon
    YONSEI MEDICAL JOURNAL, 2016, 57 (03) : 580 - 587
12345